K-numberK243441
Device nameNitrile Powder-Free Exam Gloves Tested for Use with Chemotherapy Drugs, Opioid Fentanyl Citrate, Simulated Gastric Acid (Light blue, Dark blue)
ApplicantBasic Medical Technology, Inc.
Product codeLZA
Device classClass I
Decision dateJan 31, 2025
DecisionSubstantially Equivalent
Regulation880.6250
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

This is a disposable nitrile powder-free examination glove made from synthetic nitrile latex in light blue and dark blue colors. It is designed to protect examiners during patient contact and has been specifically tested for use with chemotherapy drugs, fentanyl citrate, and simulated gastric acid. The gloves come in sizes XS through XXL, are non-sterile, single-use, ambidextrous with beaded cuffs, and fingertip textured.

Technological characteristics

The device matches the predicate device in dimensions, thickness (minimum 0.05 mm for both palm and finger), physical properties (tensile strength minimum 14 MPa, elongation 500% before aging and 400% after), powder residue (≤2 mg per glove), biocompatibility properties, and permeation resistance to most chemotherapy drugs. The primary difference is color: the subject device comes in light blue and dark blue variants, while the predicate is blue only. Both meet ASTM D6319-19 specifications for nitrile examination gloves.

Test standards cited

ASTM D6319-19 (nitrile examination glove specification), ASTM D5151-19 (hole detection), ASTM D6124-06 (residual powder), ASTM D412-16 (tensile properties), ASTM D6978-05 (chemotherapy drug permeation), ISO 10993-10:2021 (skin sensitization), ISO 10993-23:2021 (skin irritation), ISO 10993-11:2017 (acute systemic toxicity).

Substantial equivalence argument

The subject device is substantially equivalent because it is identical in all critical performance characteristics to the legally marketed predicate device K240051: same material, same class, same intended use, same regulatory requirements, same sizes, and equivalent or superior permeation performance against 39 chemotherapy drugs and fentanyl/gastric acid. The color difference (light blue and dark blue versus blue) does not raise safety or effectiveness concerns because the device maintains all specified performance requirements and biocompatibility properties, with test results demonstrating performance comparable to or better than the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →